Molecular analysis of the mitochondrial genome in South African patients with suspected mitochondrial disorders / by Anna Catharina van Brummelen

Human mitochondrial DNA (mtDNA) contains 37 genes, which encode 13 proteins (all subunits of the respiratory chain), 22 transfer ribonucleic acids (tRNA), and two ribosomal RNAs. The mtDNA mutation rate is approximately 10 times higher than that of nuclear DNA and mutations therefore accumulate more...

Full description

Bibliographic Details
Main Author: Van Brummelen, Anna Catharina
Published: North-West University 2009
Online Access:http://hdl.handle.net/10394/291
id ndltd-NWUBOLOKA1-oai-dspace.nwu.ac.za-10394-291
record_format oai_dc
spelling ndltd-NWUBOLOKA1-oai-dspace.nwu.ac.za-10394-2912014-04-16T03:54:52ZMolecular analysis of the mitochondrial genome in South African patients with suspected mitochondrial disorders / by Anna Catharina van BrummelenVan Brummelen, Anna CatharinaHuman mitochondrial DNA (mtDNA) contains 37 genes, which encode 13 proteins (all subunits of the respiratory chain), 22 transfer ribonucleic acids (tRNA), and two ribosomal RNAs. The mtDNA mutation rate is approximately 10 times higher than that of nuclear DNA and mutations therefore accumulate more rapidly. mtDNA damage may result in mitochondrial dysfunction and consequently disease, especially in those tissues most reliant on energy. Therefore, these disorders are often associated with neuromuscular syndromes, are characterised by extensive clinical variation, and are difficult to diagnose. During this investigation 42 samples from 34 South African paediatric patients with suspected mitochondrial disorders were amplified, sequenced and screened for 24 pathogenic mtDNA mutations in the tRNA-Leu(UUR), tRNA-Lys and ATPase 6 mitochondrial genes. Whole mtDNA genome sequencing and screening were performed on four patients with mitochondrial disease criteria scores of eight. The nucleotide sequences were compared to the 2001 revised Cambridge reference sequence for any discrepancies. DNA isolated from whole blood was analysed, except for seven patients for whom DNA could be isolated from both blood and muscle. A total of 103 different reported polymorphisms, 44 different novel synonymous alterations and 17 different potentially pathogenic mutations were detected. None of the detected alterations were reported pathogenic mutations but the 956-965insCCCCC, T2416C, C3254T, G7979A and A13276G alterations should certainly be investigated further. Haplogroup analysis was performed for the four patients with whole mtDNA genome sequence data, as haplogroups can influence disease expression. Heteroplasmy was not detected for any of the alterations. However, it was demonstrated that low levels of heteroplasmy, detectable via restriction fragment length polymorphism analysis, remain undetected by cycle sequencing. Possible explanations for not detecting reported mutations could be that the pathogenic mutations are nuclear encoded, present in other tissues or that a novel aetiology accounts for mitochondrial disorders in the South African population.Thesis (M.Sc. (Biochemistry))--North-West University, Potchefstroom Campus, 2004.North-West University2009-01-30T12:49:05Z2009-01-30T12:49:05Z2003Thesishttp://hdl.handle.net/10394/291
collection NDLTD
sources NDLTD
description Human mitochondrial DNA (mtDNA) contains 37 genes, which encode 13 proteins (all subunits of the respiratory chain), 22 transfer ribonucleic acids (tRNA), and two ribosomal RNAs. The mtDNA mutation rate is approximately 10 times higher than that of nuclear DNA and mutations therefore accumulate more rapidly. mtDNA damage may result in mitochondrial dysfunction and consequently disease, especially in those tissues most reliant on energy. Therefore, these disorders are often associated with neuromuscular syndromes, are characterised by extensive clinical variation, and are difficult to diagnose. During this investigation 42 samples from 34 South African paediatric patients with suspected mitochondrial disorders were amplified, sequenced and screened for 24 pathogenic mtDNA mutations in the tRNA-Leu(UUR), tRNA-Lys and ATPase 6 mitochondrial genes. Whole mtDNA genome sequencing and screening were performed on four patients with mitochondrial disease criteria scores of eight. The nucleotide sequences were compared to the 2001 revised Cambridge reference sequence for any discrepancies. DNA isolated from whole blood was analysed, except for seven patients for whom DNA could be isolated from both blood and muscle. A total of 103 different reported polymorphisms, 44 different novel synonymous alterations and 17 different potentially pathogenic mutations were detected. None of the detected alterations were reported pathogenic mutations but the 956-965insCCCCC, T2416C, C3254T, G7979A and A13276G alterations should certainly be investigated further. Haplogroup analysis was performed for the four patients with whole mtDNA genome sequence data, as haplogroups can influence disease expression. Heteroplasmy was not detected for any of the alterations. However, it was demonstrated that low levels of heteroplasmy, detectable via restriction fragment length polymorphism analysis, remain undetected by cycle sequencing. Possible explanations for not detecting reported mutations could be that the pathogenic mutations are nuclear encoded, present in other tissues or that a novel aetiology accounts for mitochondrial disorders in the South African population. === Thesis (M.Sc. (Biochemistry))--North-West University, Potchefstroom Campus, 2004.
author Van Brummelen, Anna Catharina
spellingShingle Van Brummelen, Anna Catharina
Molecular analysis of the mitochondrial genome in South African patients with suspected mitochondrial disorders / by Anna Catharina van Brummelen
author_facet Van Brummelen, Anna Catharina
author_sort Van Brummelen, Anna Catharina
title Molecular analysis of the mitochondrial genome in South African patients with suspected mitochondrial disorders / by Anna Catharina van Brummelen
title_short Molecular analysis of the mitochondrial genome in South African patients with suspected mitochondrial disorders / by Anna Catharina van Brummelen
title_full Molecular analysis of the mitochondrial genome in South African patients with suspected mitochondrial disorders / by Anna Catharina van Brummelen
title_fullStr Molecular analysis of the mitochondrial genome in South African patients with suspected mitochondrial disorders / by Anna Catharina van Brummelen
title_full_unstemmed Molecular analysis of the mitochondrial genome in South African patients with suspected mitochondrial disorders / by Anna Catharina van Brummelen
title_sort molecular analysis of the mitochondrial genome in south african patients with suspected mitochondrial disorders / by anna catharina van brummelen
publisher North-West University
publishDate 2009
url http://hdl.handle.net/10394/291
work_keys_str_mv AT vanbrummelenannacatharina molecularanalysisofthemitochondrialgenomeinsouthafricanpatientswithsuspectedmitochondrialdisordersbyannacatharinavanbrummelen
_version_ 1716664134461816832